P
Percutek Therapeutics
Percutek Therapeutics is a Medical device developer
About Percutek Therapeutics
Beijing Percutek Therapeutics Inc. is a high-tech enterprise dedicated to the research, development, production, and sales of innovative medical devices aimed at treating vascular diseases. The company serves healthcare providers and patients in need of advanced solutions for aortic artery, peripheral and coronary artery, neuro intervention, and vascular access treatments. Operating in the medical technology market, Beijing Percutek Therapeutics focuses on addressing unmet clinical needs through independent research and development. The business model revolves around creating cutting-edge medical devices that improve patient outcomes and are commercially viable. Revenue is generated through the sale of these specialized medical devices to hospitals, clinics, and healthcare facilities.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 18.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | Jun 2019 | $15M | $58M | General Technology Venture Capital · Jianxin Capital | — |
| SERIES CEquity / VC | Jan 2018 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Percutek Therapeutics is 560 monthly website visits, up 69.7% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Percutek Therapeutics in the Dongcheng District ecosystem
The Percutek Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
CD Capital
Series B and later2 investors entered at this stage
- GCGeneral Technology Venture Capital
- JCJianxin Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Percutek Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Percutek Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










